Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Epilepsy in neuropathologically verified Alzheimer's disease
Univ Eastern Finland, Inst Clin Med, Unit Pathol, Kuopio, Finland;Kuopio Univ Hosp, Dept Pathol, POB 1777, FIN-70211 Kuopio, Finland.
Tampere Univ Hosp, Dept Pathol, Fimlab Labs, Tampere, Finland.
Univ Jyvaskyla, Ctr Interdisciplinary Brain Res, Jyvaskyla, Finland;Univ Jyvaskyla, Dept Psychol, Jyvaskyla, Finland.ORCID iD: 0000-0002-1641-844X
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology, Clinical and experimental pathology. (Irina Alafuzoff)
Show others and affiliations
2018 (English)In: Seizure, ISSN 1059-1311, E-ISSN 1532-2688, Vol. 58, p. 9-12Article in journal (Refereed) Published
Abstract [en]

Purpose: Subjects with Alzheimer's disease (AD) have been shown to be at a higher risk for epilepsy. The vast majority of the previous studies have not included a full neuropathological examination. Methods: The objective of this study was to assess the prevalence of epilepsy and clinicopathological characteristics in a well-defined study group of 64 subjects with AD. We evaluated the clinicopathological findings in 64 subjects (mean age at death 85 +/- 8.6 years) from a longitudi-nal study cohort of patients with dementia. Results: Eleven out of the 64 subjects (17%) had a history of epilepsy, which is comparable to previous studies. The subjects with AD and epilepsy were significantly younger at the time of AD diagnosis and at the time of hospitalisation. In addition, their duration of AD was longer. Concomitant neuropathology in addition to AD was common in both groups and the ApoE genotypes did not differ significantly between the groups. Conclusion: The strength of this study is a thorough neuropathological examination of all study subjects. Our findings support the previous literature regarding the prevalence of epilepsy in subjects with AD. We have shown that the subjects with AD and epilepsy differ significantly from the subjects without epilepsy.

Place, publisher, year, edition, pages
W B SAUNDERS CO LTD , 2018. Vol. 58, p. 9-12
Keywords [en]
Alzheimer, Dementia, Epilepsy, Autopsy, Neurodegeneration
National Category
Neurology Clinical Laboratory Medicine
Research subject
Pathology
Identifiers
URN: urn:nbn:se:uu:diva-360996DOI: 10.1016/j.seizure.2018.03.014ISI: 000436884500003PubMedID: 29602145OAI: oai:DiVA.org:uu-360996DiVA, id: diva2:1251180
Available from: 2018-09-26 Created: 2018-09-26 Last updated: 2019-01-07Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Lohvansuu, KaisaAlafuzoff, Irina
By organisation
Clinical and experimental pathology
In the same journal
Seizure
NeurologyClinical Laboratory Medicine

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 21 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf